Skip to main navigation

Top bar

Biogen.com Information Request Sign up for Alerts Search

Investor Relations

Overview

News

Events Presentations

SEC Filings Annual Reports

Stock Quote & Chart Analyst Coverage Investor FAQs

Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board

News

News

News Category

Year

September 23, 2008

Biogen Idec Announces Webcast of Presentation at the UBS Global Life Sciences Conference

September 19, 2008

TYSABRI(R) Demonstrates Sustained Improvement in Functional Outcomes in Multiple Sclerosis Patients According to New Post-Hoc Analysis

September 18, 2008

New Long-Term Data Show That Patients Taking AVONEX(R) for up to 15 Years Experience Reduced Disability Progression and Improved Quality of Life

September 18, 2008

Biogen Idec Features Data on AVONEX(R) and TYSABRI(R) and Showcases the Company's Multiple Sclerosis Development Pipeline at the World Congress On Treatment and Research in Multiple Sclerosis

September 5, 2008

Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology

September 4, 2008

Biogen Idec to Present at the 3rd Annual CITI Biotech Day

August 26, 2008

Biogen Idec to Present at the Thomas Weisel Partners Healthcare Conference

August 21, 2008

Biogen Idec Initiates Phase III Clinical Trial for ADENTRI(R) in Acute Decompensated Heart Failure Patients with Renal Insufficiency

July 31, 2008

Biogen Idec and Elan Will Host a Conference Call For the Investment Community

July 24, 2008

Biogen Idec Names Brian S. Posner to Board of Directors

Pagination

First page
Previous page
…
Page 69
Page 70
Page 71
Page 72
Current page 73
Page 74
Page 75
Page 76
Page 77
Next page
Last page

Displaying 721 - 730 of 763

Footer

Investors
Careers
Our Stories
Contact Us

Follow us

Bottom

Privacy Policy
Terms & Conditions
Forward-Looking Statements
Community Guidelines

Investor Relations

Overview

News

Events & Presentations

Events
Presentations

Financials

SEC Filings
Annual Reports

Stock Information

Stock Quote & Chart
Analyst Coverage
Investor FAQs

Corporate Governance

Governance Documents
Committee Composition & Charters
Leadership
Code of Business Conduct
Contact the Board

Top bar

Biogen.com

Information Request

Sign up for Alerts

Search

Follow us